Chembio Diagnostics Inc (CEMI)

[hotonthemoney]

"Achieved second quarter 2021 total revenue of $6.5 million and product revenue of $3.9 million, representing growth of 26% and 4%, respectively, compared to the prior year period
Initiated shipments under a $28.3 million purchase order for DPP SARS-CoV-2 Antigen Tests received from Bio-Manguinhos to support the urgent needs of Brazil’s Ministry of Health for delivery during 2021
Received a $4.0 Million HIV Test purchase order supported by The Global Fund for shipment to Ethiopia into early 2022
Continued clinical trials for the DPP SARS-CoV-2 Antigen Test System, intended for use in applications for a new EUA and a 510(k)
Launched an at the market (“ATM”) offering of common stock and raised $36.9 million of gross proceeds in July
"